Today: 10 June 2026
Browse Category

NASDAQ:ADBE 8 February 2026 - 6 June 2026

ServiceNow Stock Gains as Wall Street AI Trade Turns

ServiceNow Stock Gains as Wall Street AI Trade Turns

ServiceNow soared 8.5% to $134.95 in heavy trading after Nvidia CEO Jensen Huang dismissed fears that AI agents will replace software firms, calling it “exactly the opposite.” Salesforce, IBM, and Adobe also rallied as investors rotated back into software stocks. ServiceNow reported Q1 subscription revenue up 22% to $3.67 billion and a 130%+ jump in $1M+ Now Assist customers. Risks flagged include competition, AI adoption, macro factors, and FX.
Adobe Stock Gains in Premarket With Wall Street Focused on AI

Adobe Stock Gains in Premarket With Wall Street Focused on AI

Adobe surged 3.6% after hours to $268.48, building on Friday’s 7.36% rally, as investors await June 11 earnings for proof AI boosts revenue, not just costs. The stock remains far below its $421 high. Adobe’s $25 billion buyback runs through 2030. CEO Narayen will step down after a successor is named. Competition from Figma and new AI tools like Anthropic’s Claude Design adds pressure ahead of the key earnings report.
Figma Inc Sets May 14 Earnings Date as AI Competition, Board Changes Raise Stakes

Figma Inc Sets May 14 Earnings Date as AI Competition, Board Changes Raise Stakes

Figma will report first-quarter results on May 14 after U.S. markets close, amid rising competition from AI-driven rivals like Anthropic and Adobe. Director Mamoon Hamid will not seek re-election, and Anthropic’s Mike Krieger resigned from the board April 14. Figma projected 2026 revenue above analyst estimates in February, but warned in filings that AI tools could pressure growth and margins. CEO Dylan Field controls 72.3% of voting power.
US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

US Stock Market Today: Wall Street Rises Again, but Oil and Fed Fears Keep the Rally on Edge

The Dow rose 337 points, or 0.7%, by 1 p.m. Thursday as oil prices retreated after Israel announced direct talks with Lebanon and hopes for a U.S.-Iran ceasefire steadied markets. Amazon shares climbed on news its AWS AI services topped $15 billion in annualized revenue. The Fed signaled possible rate hikes if inflation persists. Oil shipments through the Strait of Hormuz remained sharply reduced.
S&P 500, Nasdaq and Dow Slip Again as $100 Brent and Soft GDP Rattle Wall Street

S&P 500, Nasdaq and Dow Slip Again as $100 Brent and Soft GDP Rattle Wall Street

Wall Street fell Friday, with the Nasdaq down 0.91% and the S&P 500 off 0.38% as Brent crude stayed above $100. U.S. GDP growth was revised down to 0.7% for Q4, while January’s core PCE inflation hit 3.1%. Morgan Stanley limited withdrawals from a private-credit fund amid industry stress. Adobe shares dropped 6.4% after CEO Shantanu Narayen announced plans to step down.
What to Know About AI Stocks Before the US Market Open Today: Oracle Revives the Trade, Adobe Up Next

What to Know About AI Stocks Before the US Market Open Today: Oracle Revives the Trade, Adobe Up Next

Oracle reported a 325% jump in contracted future revenue to $553 billion and raised its 2027 revenue target to $90 billion, driving AI stocks higher premarket despite oil prices weighing on futures. Nvidia announced a $2 billion investment in Nebius, while Meta unveiled four in-house AI chips. Amazon is seeking $37 billion in bonds to fund AI infrastructure. Atlassian will cut 1,600 jobs to shift focus to AI.
Adobe stock jumps as Wall Street fixates on AI recurring revenue ahead of earnings

Adobe stock jumps as Wall Street fixates on AI recurring revenue ahead of earnings

Adobe shares jumped 3.9% to $283.86 on Thursday as investors focused on AI-driven recurring revenue ahead of next week’s earnings. Piper Sandler maintained a Neutral rating, while Barclays trimmed its price target to $335 but stayed positive. Analysts highlighted annual recurring revenue and AI adoption as key metrics. The stock remains about 40% below its 52-week high.
Adobe stock price slips again as AI and rate jitters hit software — what’s next for ADBE

Adobe stock price slips again as AI and rate jitters hit software — what’s next for ADBE

Adobe shares fell 1.4% to $253.66 in Thursday afternoon trading, tracking a 2.7% drop in the S&P 500 software and services index. Investors cited concerns over AI disruption and shifting U.S. rate expectations ahead of Friday’s inflation data. The stock is down nearly 45% from its February 2025 high. Adobe’s next earnings call is set for March 12.
1 2 3 9

Stock Market Today

  • Kalshi Co-Founder Predicts Prediction Markets Will Surpass Stock Exchanges
    June 10, 2026, 5:42 PM EDT. Kalshi co-founder and COO Luana Lopes Lara stated at Web Summit Rio on June 10, 2026, that prediction markets could become larger than traditional stock exchanges despite potential losses for participants. Prediction markets involve trading contracts based on event outcomes, differing from equity markets by focusing on future predictions rather than ownership. Lopes Lara highlighted Kalshi's readiness to collaborate closely with regulatory bodies to ensure compliance and foster growth. This outlook underscores the growing interest in alternative trading platforms challenging conventional financial markets.

Latest articles

YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Go toTop